RESUMEN
El síndrome de Burnout también conocido con el término "de estar quemado" afecta de manera negativa la calidad de vida, salud mental y laboral del personal de salud, éste se pudo ver afectado en el período post pandemia, dado que la emergencia sanitara generó mayor estrés, manteniendo a las personas es un estado de alerta constante. Objetivo: explorar la prevalencia y factores asociados al Síndrome de Burnout en docentes de las Licenciaturas de las Ciencias de la Salud que se desarrollan en el Edificio Polivalente Parque Batlle de la Udelar durante el año 2022. Metodología: se realizó un estudio observacional descriptivo, de corte transversal. Población objetivo: docentes de las Licenciaturas de las Ciencias de la Salud de la Udelar, a los que se aplicó un cuestionario anónimo y auto administrado. El proyecto fue aprobado por el Comité de Ética de la Escuela de Nutrición. Todos los participantes dieron su consentimiento informado. Resultados: de un universo de 820 docentes, respondieron 145, predominando el sexo femenino. El 52 % con edades entre 18 y 40 años. Al evaluar los factores de Escala de Maslach encontramos que el 45 % presentó Cansancio Emocional Alto, seguido de un 18 %de Realización Personal Bajo y un 10 % de Despersonalización Alto. Dos participantes presentan las tres dimensiones de riesgo, corresponde a una prevalencia de 1.4 %. Conclusiones: si bien la prevalencia de Burnout fue baja en la serie estudiada, es importante destacar el elevado porcentaje de la dimensión cansancio emocional, el cual se refleja en una sobrecarga emocional generada por el trabajo.
Burnout syndrome, also known by the term "being burned" negatively affects the quality of life, mental health and work of health personnel, this could be affected in the post-pandemic period, since the health emergency generated greater stress , keeping people is a constant state of alert. Objective: to explore the prevalence and factors associated with Burnout Syndrome in teachers of the Health Sciences Degrees that are developed in the Parque Batlle la Udelar Multipurpose Building during the year 2022.Methodology: a descriptive, cross-sectional, observational study was carried out. Target population: professors of the Udelar Health Sciences Degrees, to whom an anonymous and self-administered questionnaire was applied. The project was approved by the Ethics Committee of the School of Nutrition. All participants gave their informed consent. Results: from a universe of 820 teachers, 145 responded, predominantly female. 52 % aged between 18 and 40 years. When evaluating the Maslach Scale factors, we found that 45 %presented High Emotional Fatigue, followed by 18 % of Low Personal Realization and 10% of High Depersonalization. Two participants presented the three dimensions of risk, corresponding to a prevalence of 1.4 %.Conclusions: although the prevalence of Burnout was low in the series studied, it is important to highlight the high percentage of the emotional exhaustion dimension, which is reflected in an emotional overload generated by work.
A síndrome de Burnout, também conhecida pelo termo "ser queimado" afeta negativamente a qualidade de vida, a saúde mental e o trabalho do pessoal de saúde, podendo ser afetado no período pós-pandemia, pois a emergência sanitária gerou maior estresse, manter as pessoas é um problema constante estado de alerta. Objetivo: explorar a prevalência e os fatores associados à Síndrome de Burnout em professores das Licenciaturas em Ciências da Saúde que se desenvolvem no Edifício Multiuso Parque Batlle de la Udelar durante o ano de 2022.Metodologia: estudo descritivo, transversal e observacional. População-alvo: docentes dos Cursos de Ciências da Saúde da Udelar, aos quais foi aplicado um questionário anônimo e autoaplicável. O projeto foi aprovado pelo Comitê de Ética da Escola de Nutrição. Todos os participantes deram o seu consentimento informado. Resultados: de um universo de 820 professores, 145 responderam, predominantemente do sexo feminino, 52 % com idade entre 18 e 40 anos. Ao avaliar os fatores da Escala de Maslach, verificamos que 45 % apresentaram Alta Fadiga Emocional, seguidos de 18 % de Baixa Realização Pessoal e 10 % de Alta Despersonalização. Dois participantes apresentaram as três dimensões de risco, correspondendo a uma prevalência de 1,4 %.Conclusões: embora a prevalência de Burnout tenha sido baixa na série estudada, é importante destacar o alto percentual da dimensão exaustão emocional, que se reflete em uma sobrecarga emocional gerada pelo trabalho.
Asunto(s)
Humanos , Universidades , Uruguay , Agotamiento Profesional , Docentes , Agotamiento Psicológico , COVID-19RESUMEN
Introduction: Tuberculosis (TB) is a major health problem characterized by an immuno-endocrine imbalance: elevated plasma levels of cortisol and pro- and anti-inflammatory mediators, as well as reduced levels of dehydroepiandrosterone. The etiological agent, Mycobacterium tuberculosis (Mtb), is captured by pulmonary macrophages (Mf), whose activation is necessary to cope with the control of Mtb, however, excessive activation of the inflammatory response also leads to tissue damage. Glucocorticoids (GC) are critical elements to counteract the immunoinflammatory reaction, and peroxisome proliferator-activated receptors (PPARs) are also involved in this regard. The primary forms of these receptors are PPARÏ, PPARα, and PPARß/δ, the former being the most involved in anti-inflammatory responses. In this work, we seek to gain some insight into the contribution of PPARÏ in immuno-endocrine-metabolic interactions by focusing on clinical studies in pulmonary TB patients and in vitro experiments on a Mf cell line. Methods and results: We found that TB patients, at the time of diagnosis, showed increased expression of the PPARÏ transcript in their peripheral blood mononuclear cells, positively associated with circulating cortisol and related to disease severity. Given this background, we investigated the expression of PPARÏ (RT-qPCR) in radiation-killed Mtb-stimulated human Mf. The Mtb stimulation of Mf derived from the human line THP1 significantly increased the expression of PPARÏ, while the activation of this receptor by a specific agonist decreased the expression of pro- and anti-inflammatory cytokines (IL-1ß and IL-10). As expected, the addition of GC to stimulated cultures reduced IL-1ß production, while cortisol treatment together with the PPARÏ agonist lowered the levels of this proinflammatory cytokine in stimulated cultures. The addition of RU486, a glucocorticoid receptor antagonist, only reversed the inhibition produced by the addition of GC. Conclusion: The current results provide a stimulating background for further analysis of the interconnection between PPARs and steroid hormones in the context of Mtb infection.
Asunto(s)
Mycobacterium tuberculosis , Tuberculosis , Humanos , PPAR gamma/metabolismo , PPAR gamma/farmacología , Hidrocortisona/farmacología , Hidrocortisona/metabolismo , Leucocitos Mononucleares/metabolismo , Tuberculosis/metabolismo , Mycobacterium tuberculosis/metabolismo , Citocinas/metabolismoRESUMEN
Introduction: Anti-COVID vaccination in Argentina was carried out using different protocols and variations in periods between administrations, as well as combinations of different vaccine platforms. Considering the relevance of the antibody response in viral infections, we analyzed anti-S antibodies in healthy people at different points of time following the Sputnik immunization procedure. Methods: We attended the vaccination centers in the city of Rosario, which had shorter versus longer intervals between both doses. A total of (1021) adults with no COVID-compatible symptoms (throughout the study period) were grouped according to the gap between both vaccine doses: 21 (Group A, n=528), 30 (Group B, n=147), and 70 days (Group C, n=82), as well as an additional group of individuals with heterologous vaccination (Sputnik/Moderna, separated by a 107-day interval, group D, n=264). Results and conclusions: While there were no between-group differences in baseline levels of specific antibodies, data collected several weeks after administering the second dose showed that group D had the highest amounts of specific antibodies, followed by values recorded in Groups C, B, and A. The same pattern of group differences was seen when measuring anti-S antibodies at 21 or 180 days after the first and second doses, respectively. Delayed between-dose intervals coexisted with higher antibody titers. This happened even more when using a prime-boost heterologous schedule.
Asunto(s)
COVID-19 , SARS-CoV-2 , Adulto , Humanos , Formación de Anticuerpos , COVID-19/prevención & control , Vacunación , InmunizaciónRESUMEN
Dehydroepiandrosterone (DHEA) is an androgen synthesized by the adrenal cortex, which is an intermediary in the biosynthesis of sex hormones, such as testosterone and estradiol. DHEA mostly circulates as a conjugated ester, in the form of sulfate (DHEA-S). There exist several endogenous factors able to influence its synthesis, the most common ones being the corticotrophin-releasing hormone (CRH), adrenocorticotrophin (ACTH), growth factors, and proinflammatory cytokines, among others. Like other steroid hormones, DHEA, can alter the functioning of immune cells and therefore the course of diseases exhibiting an immune-inflammatory component, mostly from autoimmune or infectious nature. We herein review the role played by DHEA during a major infectious disease like tuberculosis (TB). Data recorded from TB patients, mouse models, or in vitro studies show that DHEA is likely to be implied in better disease control. This provides a stimulating background for carrying out clinical studies aimed at assessing the usefulness of DHEA as an adjuvant in TB patients.
Asunto(s)
Corteza Suprarrenal , Tuberculosis , Corteza Suprarrenal/metabolismo , Hormona Adrenocorticotrópica/metabolismo , Andrógenos/metabolismo , Animales , Sulfato de Deshidroepiandrosterona/metabolismo , Humanos , Ratones , Tuberculosis/tratamiento farmacológicoRESUMEN
AIMS: Previous studies in TB patients showed an immuno-endocrine imbalance characterized by a disease-severity associated increase in plasma levels of proinflammatory cytokines and glucocorticoids (GCs). To analyze the potential immunomodulatory effect of circulating GCs over peripheral blood mononuclear cells (PBMC) from TB patients, we investigated the expression of positively (anti-inflammatory-related genes ANXA1; FKBP51; GILZ, NFKBIA, and NFKBIB) and negatively (inflammatory genes: IL-6, IL-1ß, and IFN-γ) Glucocorticoids Receptors (GR)-regulated genes. Plasma concentrations of cytokines and hormones, together with specific lymphoproliferation were also assessed. MATERIALS AND METHODS: Gene expression was quantified by RT-qPCR, specific lymphoproliferation by 3H-thymidine incorporation, whereas plasma cytokines and hormones levels by ELISA. KEY FINDINGS: Transcripts of ANXA1, GILZ, NFKBIB, and NFKBIA appeared significantly increased in patients, whereas FKBP51, IL-6, IL-1ß, and NF-κB remained unchanged. Upon analyzing according to disease severity, mRNA levels for ANXA1 and NFKBIB were even higher in moderate and severe patients. GILZ was increased in moderate cases, with NFKBIA and IL-1 ß being higher in severe ones, who also displayed increased GRß transcripts. TB patients had reduced plasma DHEA concentrations together with increased pro and anti-inflammatory cytokines (IFN-γ, IL-6, and IL-10) cortisol and cortisol/DHEA ratio, more evident in progressive cases, in whom their PBMC also showed a decreased mycobacterial-driven proliferation. The cortisol/DHEA ratio and GRα expression were positively correlated with GR-regulated genes mainly in moderate patients. SIGNIFICANCE: The increased expression of cortisol-regulated anti-inflammatory genes in TB patients-PBMC, predominantly in progressive disease, seems compatible with a relatively insufficient attempt to downregulate the accompanying inflammation.
Asunto(s)
Receptores de Glucocorticoides , Tuberculosis Pulmonar , Citocinas/metabolismo , Deshidroepiandrosterona/farmacología , Glucocorticoides/farmacología , Humanos , Hidrocortisona/metabolismo , Interleucina-6/metabolismo , Leucocitos Mononucleares/metabolismo , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/metabolismo , Tuberculosis Pulmonar/genética , Tuberculosis Pulmonar/metabolismoRESUMEN
Our earlier studies in tuberculosis (TB) patients indicate that in those where the process evolves to a larger pulmonary involvement, the immune endocrine response may promote an unfavorable environment. Chronic infectious diseases, and their persistent proinflammatory response, may affect mucosal barriers integrity favoring the translocation of gastrointestinal bacteria, leading to an increase of circulating lipopolysaccharides (LPS). Consequently, we quantified LPS levels in TB patients, with different degrees of pulmonary involvement, and controls (Co) and analyzed the possible relationship between LPS and inflammatory mediators i.e., C reactive protein (CRP), interleukin 6 (IL-6) and Interferon-gamma (IFN-γ), Erythrocyte Sedimentation Rate (ESR), steroid hormones (Cortisol and Dehydroepiandrosterone, DHEA), and inflammatory transcripts from peripheral blood mononuclear cells (IL-1ß, IL-6, IFN-γ). LPS was assessed by the Limulus amoebocyte lysate assay and the ELISA technique was used to quantify hormones and cytokines in the plasma samples. Cytokine transcripts from PBMC were evaluated by qRT-PCR. Non-parametric tests were used. LPS levels were increased in TB patients, as did levels of CRP, IL-6, IFN-γ, cortisol and ESR. Severe patients had the highest amounts of circulating LPS; with moderate and severe cases showing much higher levels of CRP, ESR, IL-6, IFN-γ and cortisol/DHEA ratio, as an endocrine imbalance. Only in PBMC from severe cases was mRNA for IL-1ß increased. Correlation analysis showed that levels of LPS from severe patients were positively associated with IL-6 and IFN-γ plasma concentrations and with IL-1ß transcripts, while IL-6 had a positive correlation with the cortisol/DHEA ratio. The higher levels of circulating LPS during progressive TB may emerge as a contributing factor for the persistence of the greater immune endocrine imbalance distinctive of advanced disease, which might suggest a vicious cycle among LPS, inflammation and endocrine imbalance.
Asunto(s)
Lipopolisacáridos/sangre , Tuberculosis/sangre , Adolescente , Adulto , Anciano , Proteína C-Reactiva/metabolismo , Humanos , Interferón gamma/sangre , Interleucina-1beta/sangre , Interleucina-6/sangre , Leucocitos Mononucleares/metabolismo , Persona de Mediana Edad , Mycobacterium tuberculosis/metabolismo , Adulto JovenRESUMEN
INTRODUCCIÓN: En 2019, surgió un nuevo coronavirus que causó una pandemia mundial. Durante 2020, se desarrollaron vacunas con aceptable seguridad y eficacia para disminuir complicaciones y muertes. El presente trabajo se propuso investigar la relación entre la vacunación y el contagio entre convivientes. MÉTODOS: Se analizaron datos del Registro Federal de Vacunación Nominalizado y los casos confirmados en provincia de Santa Fe registrados en el Sistema Integrado de Información Sanitaria Argentina desde 1 de enero hasta 30 de junio de 2021 en personas de 18 a 65 años. Se constituyeron 5291 pares de un caso índice y un caso secundario, cuyos domicilios coincidían y cuyas fechas de inicio de síntomas se hallaban en un rango de 2 a 14 días. Se seleccionaron los pares en los que una persona estaba vacunada y la otra no, con un total de 494 pares. RESULTADOS: El promedio de edad de los casos índice fue de 40,8 años y el de los secundarios fue de 40,5 años. Se hallaron 234 personas vacunadas entre los casos índice y 386 entre los secundarios. De los 494 pares con una persona vacunada y una no vacunada, el caso índice fue la persona vacunada en 179 pares, y en 315 pares el índice fue la persona no vacunada. DISCUSIÓN: El análisis sugiere que, en los contagios intradomiciliarios, donde se involucran personas vacunadas y no vacunadas, es más frecuente que sea la persona no vacunada quien constituya el caso índice. Esto señala la importancia de vacunar a los convivientes de las personas con factores de riesgo.
Asunto(s)
Transmisión de Enfermedad Infecciosa , Vacunas contra la COVID-19 , COVID-19RESUMEN
ABSTRACT The SARS-CoV-2, a newly identified β-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infect humans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain, Italy, United Kingdom, Russia, France and Germany with over 223.000, 218.000, 215.000, 209.000, 176.000, and 171.000 cases, respectively.
Asunto(s)
Humanos , Neumonía Viral/epidemiología , Infecciones por Coronavirus/epidemiología , Pandemias , Betacoronavirus , SARS-CoV-2 , COVID-19RESUMEN
The SARS-CoV-2, a newly identified ß-coronavirus, is the causative agent of the third large-scale pandemic from the last two decades. The outbreak started in December 2019 in Wuhan City, Hubei province in China. The patients presented clinical symptoms of dry cough, fever, dyspnea, and bilateral lung infiltrates on imaging. By February 2020, The World Health Organization (WHO) named the disease as Coronavirus Disease 2019 (COVID-19). The Coronavirus Study Group (CSG) of the International Committee on Taxonomy of Viruses (ICTV) recognized and designated this virus as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 uses the same host receptor, angiotensin-converting enzyme 2 (ACE2), used by SARS-CoV to infect humans. One hypothesis of SARSCoV-2 origin indicates that it is likely that bats serve as reservoir hosts for SARSCoV-2, being the intermediate host not yet determined. The predominant route of transmission of SARS-CoV-2 is from human to human. As of May 10th 2020, the number of worldwide confirmed COVID-19 cases is over 4 million, while the number of global deaths is around 279.000 people. The United States of America (USA) has the highest number of COVID-19 cases with over 1.3 million cases followed by Spain, Italy, United Kingdom, Russia, France and Germany with over 223.000, 218.000, 215.000, 209.000, 176.000, and 171.000 cases, respectively.
Asunto(s)
Infecciones por Coronavirus/epidemiología , Neumonía Viral/epidemiología , Betacoronavirus , COVID-19 , Humanos , Pandemias , SARS-CoV-2RESUMEN
Given the role of host defense peptides (HDPs) in the defensive response against mycobacteria, we analyzed the circulating levels of LL-37, ß-defensin-2 and -3 in newly diagnosed patients with pulmonary (PTB) or pleural tuberculosis (PLTB) in whom measurements of pleural fluids were also performed. Severe PTB patients displayed higher circulating amounts of ß-defensin-3, statistically different from controls, further decreasing upon antimycobacterial treatment. LL-37 concentrations appeared within the normal range at diagnosis, but tended to increase during treatment, becoming statistically upon its completion in moderate cases. PLTB patients revealed decreased levels of ß-defensin-2 in presence of increased amounts of ß-defensin-3 and LL-37; in their plasma or pleural fluids. Considering the immune-endocrine dysregulation of tuberculosis, we also performed correlation analysis detecting positive associations between levels of cortisol, IL-6 and ß-defensin-3 in plasma from untreated severe patients as did their dehydroepiandrosterone and LL-37 values. Increased presence of ß-defensins, may represent an attempt to improve defensive mechanisms; which also take part in the inflammatory reaction accompanying TB, reinforced by the association with immune-endocrine mediators. The divergent profile of PLTB patients, decreased ß-defensin-2 but increased ß-defensin-3 and LL-37 levels, suggests a differential role of these HDPs in a situation characterized for its better protective response.
Asunto(s)
Péptidos Catiónicos Antimicrobianos/sangre , Mycobacterium tuberculosis/inmunología , Tuberculosis Pleural/patología , Tuberculosis Pulmonar/patología , beta-Defensinas/sangre , Adulto , Deshidroepiandrosterona/sangre , Femenino , Humanos , Hidrocortisona/sangre , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Índice de Severidad de la Enfermedad , Tuberculosis Pleural/sangre , Tuberculosis Pulmonar/sangre , Adulto Joven , CatelicidinasRESUMEN
INTRODUCTION: IL-1ß, a cytokine from the innate immune response, is well known for its proinflammatory effects and stimulating activity on the hypothalamus-pituitary-adrenal axis, leading to the pituitary synthesis of adrenocorticotropic hormone followed by cortisol (and dehydroepiandrosterone - DHEA) release by the adrenal gland. While IL-1ß modulates the adrenal steroidogenesis at the central level, it is unclear whether it also exerts an effect on the adrenal gland. METHOD: We studied the effect of IL-1ß on adrenal steroid production and steroidogenic enzyme RNA expression in the human cell line NCI-H295R. We also explored eventual changes in the microRNA (miRNA) profile from IL-1ß-treated NCI-H295R cells. RESULTS: Transcripts encoding IL-1ß receptors 1 and 2 were noticeable in the cell line, with cortisol and DHEA production showing a subtle increase after cytokine treatment. Transcripts from key enzymes in the steroidogenic pathway were analyzed, with no noticeable changes on them. The miRNA profile was modified by IL-1ß treatment to an extent which bears some relationship with the regulatory mechanisms underlying adrenal steroid production. Since orphan nuclear receptors NR4As have emerged as potential key factors for coordinating inflammatory and metabolic responses, cell expression studies were also carried out to show an NR4As transcript augmentation following IL-1ß treatment. DISCUSSION/CONCLUSIONS: The subtle increase in adrenal steroid production in response to IL-1ß stimulation without any modification in the transcription of the steroidogenic enzymes analyzed suggests an additional inflammatory/anti-inflammatory loop, wherein NR4As receptors may participate. Besides its physiological role, this process might be implied in pathological states accompanied by an unbalanced immune-endocrine relationship.
Asunto(s)
MicroARNs , Receptores Nucleares Huérfanos , Línea Celular , Humanos , Hidrocortisona , MicroARNs/genética , EsteroidesRESUMEN
Upon the pathogen encounter, the host seeks to ensure an adequate inflammatory reaction to combat infection but at the same time tries to prevent collateral damage, through several regulatory mechanisms, like an endocrine response involving the production of adrenal steroid hormones. Our studies show that active tuberculosis (TB) patients present an immune-endocrine imbalance characterized by an impaired cellular immunity together with increased plasma levels of cortisol, pro-inflammatory cytokines, and decreased amounts of dehydroepiandrosterone. Studies in patients undergoing specific treatment revealed that cortisol levels remained increased even after several months of initiating therapy. In addition to the well-known metabolic and immunological effects, glucocorticoids are involved in thymic cortical depletion with immature thymocytes being quite sensitive to such an effect. The thymus is a central lymphoid organ supporting thymocyte T-cell development, i.e., lineage commitment, selection events and thymic emigration. While thymic TB is an infrequent manifestation of the disease, several pieces of experimental and clinical evidence point out that the thymus can be infected by mycobacteria. Beyond this, the thymic microenvironment during TB may be also altered because of the immune-hormonal alterations. The thymus may be then an additional target of organ involvement further contributing to a deficient control of infection and disease immunopathology.
RESUMEN
Tuberculosis (TB) caused by Mycobacterium tuberculosis is a health problem worldwide. Patients with pulmonary TB show a neuro-immune-endocrine imbalance characterized by an impaired cellular immunity together with increased plasma levels of cortisol, pro- and anti-inflammatory cytokines and markedly decreased dehydroepiandrosterone (DHEA) levels. Extending these findings, we now investigated the immune-endocrine profile of TB patients undergoing specific treatment. Patients (n = 24) were bled at diagnosis (T0), 2, 4, 6 months after treatment initiation and 3 months following its completion. At T0, TB patients showed increased plasma levels of interleukin-6 (IL-6), C reactive protein, interferon-gamma (IFN-γ) and transforming growth factor beta (TGF-ß). These mediators decreased during treatment, reaching levels similar to those from healthy controls (n = 26). Specific treatment led to an increased lymphoproliferative response along with clinical improvement. Newly diagnosed patients had low levels of DHEA, with increased cortisol amounts and cortisol/DHEA ratio, which normalized upon specific treatment. As regards glucocorticoid receptors (GR), TB patients at diagnosis presented a reduced mRNA GRα/GRß ratio in their peripheral blood mononuclear cells. Furthermore, multivariate analysis showed that cortisol/DHEA ratio was positively associated with inflammatory mediators for which this ratio may constitute a disease biomarker. Anti-mycobacterial treatment results in a better immune-endocrine scenario for the control of physiopathological processes accompanying disease development and hence implied in clinical recovery.
Asunto(s)
Antituberculosos/uso terapéutico , Regulación de la Expresión Génica/efectos de los fármacos , Leucocitos Mononucleares/efectos de los fármacos , Mycobacterium tuberculosis/efectos de los fármacos , Tuberculosis Pulmonar/tratamiento farmacológico , Adulto , Proteína C-Reactiva/genética , Proteína C-Reactiva/inmunología , Estudios de Casos y Controles , Deshidroepiandrosterona/sangre , Etambutol/uso terapéutico , Femenino , Regulación de la Expresión Génica/inmunología , Humanos , Hidrocortisona/sangre , Interferón gamma/genética , Interferón gamma/inmunología , Interleucina-6/genética , Interleucina-6/inmunología , Isoniazida/uso terapéutico , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/microbiología , Masculino , Persona de Mediana Edad , Mycobacterium tuberculosis/crecimiento & desarrollo , Mycobacterium tuberculosis/patogenicidad , Pirazinamida/uso terapéutico , Receptores de Glucocorticoides/genética , Receptores de Glucocorticoides/inmunología , Rifampin/uso terapéutico , Factor de Crecimiento Transformador beta/genética , Factor de Crecimiento Transformador beta/inmunología , Resultado del Tratamiento , Tuberculosis Pulmonar/inmunología , Tuberculosis Pulmonar/microbiología , Tuberculosis Pulmonar/patologíaRESUMEN
Tuberculous pleurisy (PLTB) is a common form of extrapulmonary tuberculosis. It often resolves without chemotherapy being hence considered a rather benign manifestation of the disease. Patients with PLTB mount an effective anti-mycobacterial response, unlike those with active pulmonary TB (pTB) that were shown to present an imbalance in plasma immune and endocrine mediators. In this work, we explored whether expression of the active isoform of the glucocorticoid receptor (hGRα) in the context of the inflammatory-anti-inflammatory responses of TB patients may be associated to microRNA levels. As expected, the inflammatory response triggered in patients coexists with increased circulating cortisol and altered hGRα levels in the peripheral blood mononuclear cells. However, while hGRα expression is significantly downregulated in PLTB, its levels in pTB patients are higher within the control values. These results point out to the existence of an additional mechanism tending to preserve hGRα levels probably to deal with the chronic inflammation observed in pTB. In this regard, we found that miR-30c is strongly downregulated in mononuclear cells of pTB patients compared to PLTB cases, showing an expression profile opposite to that seen with hGRα. Interestingly, low levels of miR-30c are specific for this active form of TB, as its expression is not altered in mononuclear cells from either healthy controls or patients with tuberculous or non-tuberculous pleurisy. Moreover, miR-30c and hGRα also showed an inverse expression pattern in M. tuberculosis-stimulated THP-1 macrophage cultures. In sum, our studies identify miR-30c as a specific correlate of pulmonary manifestations of TB, potentially involved in the altered glucocorticoid sensitivity observed in these patients.
Asunto(s)
MicroARNs/genética , Mycobacterium tuberculosis/patogenicidad , Tuberculosis Pulmonar/genética , Estudios de Casos y Controles , Regulación hacia Abajo , Marcadores Genéticos , Interacciones Huésped-Patógeno , Humanos , Hidrocortisona/sangre , Macrófagos/metabolismo , Macrófagos/microbiología , MicroARNs/sangre , Receptores de Glucocorticoides/sangre , Receptores de Glucocorticoides/genética , Células THP-1 , Tuberculosis Pulmonar/sangre , Tuberculosis Pulmonar/diagnóstico , Tuberculosis Pulmonar/microbiologíaRESUMEN
Tuberculosis (TB) is a major health problem requiring an appropriate cell immune response (IR) to be controlled. Since regulatory T cells (Tregs) are relevant in IR regulation, we analyzed Tregs variations throughout the course of TB treatment and its relationship with changes in immune-endocrine mediators dealing with disease immunopathology. The cohort was composed of 41 adult patients, 20 of them completing treatment and follow-up. Patients were bled at diagnosis (T0) and at 2 (T2), 4 (T4), 6 (T6), and 9 months following treatment initiation. Twenty-four age- and sex-matched healthy controls (HCo) were also included. Tregs (flow cytometry) from TB patients were increased at T0 (versus HCo P < 0.05), showing even higher values at T2 (versus T0 P < 0.01) and T4 (versus T0 P < 0.001). While IL-6, IFN-γ, TGF-ß (ELISA), and Cortisol (electrochemiluminescence, EQ) were augmented, DHEA-S (EQ) levels were diminished at T0 with respect to HCo, with cytokines and Cortisol returning to normal values at T9. Tregs correlated positively with IFN-γ (R = 0.868, P < 0.05) at T2 and negatively at T4 (R = -0.795, P < 0.05). Lowered levels of proinflammatory cytokines together with an increased frequency of Tregs of patients undergoing specific treatment might reflect a downmodulatory effect of these cells on the accompanying inflammation.
Asunto(s)
Antituberculosos/uso terapéutico , Linfocitos T Reguladores/inmunología , Tuberculosis Pulmonar/tratamiento farmacológico , Tuberculosis Pulmonar/inmunología , Adulto , Antígenos CD4/metabolismo , Sulfato de Deshidroepiandrosterona/sangre , Femenino , Citometría de Flujo , Factores de Transcripción Forkhead/metabolismo , Humanos , Hidrocortisona/sangre , Interferón gamma/sangre , Subunidad alfa del Receptor de Interleucina-2/metabolismo , Interleucina-6/sangre , Pulmón/patología , Masculino , Persona de Mediana Edad , Factor de Crecimiento Transformador beta/sangre , Tuberculosis Pulmonar/patología , Adulto JovenRESUMEN
Interferon (IFN)-γ displays a critical role in tuberculosis (TB), modulating the innate and adaptive immune responses. Previously, we reported that secretory leukocyte protease inhibitor (SLPI) is a pattern recognition receptor with anti-mycobacterial activity against Mycobacterium tuberculosis (Mtb). Herein, we determined whether IFN-γ modulated the levels of SLPI in TB patients. Plasma levels of SLPI and IFN-γ were studied in healthy donors (HDs) and TB patients. Peripheral blood mononuclear cells from HDs and patients with TB or defective IFN-γ receptor 1* were stimulated with Mtb antigen and SLPI, and IFN-γR expression levels were measured. Both SLPI and IFN-γ were significantly enhanced in plasma from those with TB compared with HDs. A direct association between SLPI levels and the severity of TB was detected. In addition, Mtb antigen stimulation decreased the SLPI produced by peripheral blood mononuclear cells from HDs, but not from TB or IFN-γR patients. Neutralization of IFN-γ reversed the inhibition of SLPI induced by Mtb antigen in HDs, but not in TB patients. Furthermore, recombinant IFN-γ was unable to modify the expression of SLPI in TB patients. Finally, IFN-γR expression was lower in TB compared with HD peripheral blood mononuclear cells. These results show that Mtb-induced IFN-γ down-modulated SLPI levels by signaling through the IFN-γR in HDs. This inhibitory mechanism was not observed in TB, probably because of the low expression of IFN-γR detected in these individuals.
Asunto(s)
Interferón gamma/metabolismo , Inhibidor Secretorio de Peptidasas Leucocitarias/metabolismo , Índice de Severidad de la Enfermedad , Tuberculosis/metabolismo , Tuberculosis/patología , Adulto , Estudios de Casos y Controles , Humanos , Interferón gamma/sangre , Inhibidor Secretorio de Peptidasas Leucocitarias/sangre , Tuberculosis/sangreRESUMEN
Our previous work on the immune-endocrine features of patients with pulmonary tuberculosis (TB) showed markedly decreased plasma levels of dehydroepiandrosterone (DHEA) together with augmented concentrations of Cortisol and pro- and anti-inflammatory cytokines. Studies in peripheral blood mononuclear cells (PBMC) indicated a lower mRNA α/ß ratio of glucocorticoid receptors -GR- together with a higher 11ß-hydroxysteroid dehydrogenase type 1 (11ßHSD1) mRNA expression in cases with severe pulmonary TB. Since Pleural TB (PLTB) is a rather benign manifestation of TB, we now analyzed the systemic and local immune-endocrine profile as well as the GRα, GRß, 11ßHSD1 and 11ßHSD2 transcripts in PBMC and pleural effusion mononuclear cells (PEMC) of patients with PLTB. PLTB patients had increased levels of IL-1ß, IL-6 and IFNγ together with reduced Cortisol and DHEA concentrations in pleural fluids. Also, a significantly increased expression of 11ßHSD1 and GRα was found in PEMC compared to PBMC. Findings point out to an appropriate immune response and a substantial inflammatory reaction, wherein the low Cortisol concentrations may be equally effective, because of the increased expression of GRα and 11ßHSD1 transcripts which may optimize the immunomodulatory properties of Cortisol.
Asunto(s)
Corticoesteroides/sangre , Citocinas/sangre , Mediadores de Inflamación/sangre , Tuberculosis Pleural/sangre , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 1/biosíntesis , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 1/genética , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 2/biosíntesis , 11-beta-Hidroxiesteroide Deshidrogenasa de Tipo 2/genética , Adulto , Anciano , Femenino , Expresión Génica , Humanos , Hidrocortisona/sangre , Masculino , Persona de Mediana Edad , Derrame Pleural/inmunología , Derrame Pleural/metabolismo , ARN Mensajero/metabolismo , Receptores de Glucocorticoides/biosíntesis , Receptores de Glucocorticoides/genética , Manejo de Especímenes/métodos , Tuberculosis Pleural/inmunologíaRESUMEN
Supernatants (SN) from cultures of peripheral blood mononuclear cells (PBMC) of tuberculosis (TB) patients inhibit dehydroepiandrosterone (DHEA) secretion by the adrenal cell line NCI-H295R. To analyze whether TGF-ß is involved in this effect, SN of PBMC from healthy controls or patients with severe TB infections, stimulated or not with Mycobacterium tuberculosis (Mtb SN), were added to adrenal cells under basal conditions or following stimulation with forskolin. Cortisol and DHEA concentrations were evaluated in supernatants of the adrenal cells cultured with or without the addition of anti-TGF-ß. Treatment with Mtb SN from TB inhibited DHEA production, and this effect was reversed when SN were treated with anti-TGF-ß. The increase in cortisol production induced by SN from TB patients was not affected by TGF-ß neutralization. Mediators released during the anti-TB immune response differentially modulate steroid production by adrenal cells, and TGF-ß is a cytokine implicated in the inhibition of DHEA production observed in TB.
Asunto(s)
Deshidroepiandrosterona/biosíntesis , Leucocitos Mononucleares/inmunología , Leucocitos Mononucleares/microbiología , Mycobacterium tuberculosis/inmunología , Factor de Crecimiento Transformador beta/antagonistas & inhibidores , Glándulas Suprarrenales/citología , Glándulas Suprarrenales/efectos de los fármacos , Glándulas Suprarrenales/metabolismo , Adulto , Estudios de Casos y Controles , Línea Celular , Colforsina/farmacología , Medios de Cultivo Condicionados , Deshidroepiandrosterona/metabolismo , Femenino , Interacciones Huésped-Patógeno/inmunología , Humanos , Hidrocortisona/biosíntesis , Técnicas In Vitro , Leucocitos Mononucleares/metabolismo , Masculino , Persona de Mediana Edad , Pruebas de Neutralización , Tuberculosis Pulmonar/inmunología , Tuberculosis Pulmonar/microbiologíaRESUMEN
We evaluated immune and endocrine status following antituberculosis treatment in HIV-negative patients with newly diagnosed tuberculosis (TB). Treatment led to a decrease in IL-6, IL-1ß, and C-reactive protein levels. Cortisol levels decreased throughout the anti-TB treatment, particularly after 4 months, but changes were less pronounced than those seen in proinflammatory mediators. Specific therapy resulted in increased dehydroepiandrosterone (DHEA) levels, which peaked after 4 months and started to decline after 6 months of treatment, reaching levels below those detected at inclusion. In contrast, in most patients, dehydroepiandrosterone sulfate (DHEAS) levels remained unchanged, although a trend toward increased concentrations was observed in a few cases 3 months after the treatment was finished. Specific therapy also resulted in more balanced cortisol/DHEA and cortisol/DHEAS ratios. Etiologic treatment involves favorable immune and endocrine changes, which may account for its beneficial effects.
Asunto(s)
Corticoesteroides/sangre , Mediadores de Inflamación/sangre , Tuberculosis Pulmonar/sangre , Tuberculosis Pulmonar/inmunología , Adulto , Antituberculosos/uso terapéutico , Proteína C-Reactiva/metabolismo , Estudios de Casos y Controles , Deshidroepiandrosterona/sangre , Sulfato de Deshidroepiandrosterona/sangre , Femenino , Humanos , Hidrocortisona/sangre , Interleucina-1beta/sangre , Interleucina-6/sangre , Masculino , Persona de Mediana Edad , Tuberculosis Pulmonar/tratamiento farmacológico , Adulto JovenRESUMEN
Tuberculosis (TB) remains the most frequent cause of illness and death from an infectious agent, and its interaction with HIV has devastating effects. We determined plasma levels of dehydroepiandrosterone (DHEA), its circulating form DHEA-suphate (DHEA-s) and cortisol in different stages of M. tuberculosis infection, and explored their role on the Th1 and Treg populations during different scenarios of HIV-TB coinfection, including the immune reconstitution inflammatory syndrome (IRIS), a condition related to antiretroviral treatment. DHEA levels were diminished in HIV-TB and HIV-TB IRIS patients compared to healthy donors (HD), HIV+ individuals and HIV+ individuals with latent TB (HIV-LTB), whereas dehydroepiandrosterone sulfate (DHEA-s) levels were markedly diminished in HIV-TB IRIS individuals. HIV-TB and IRIS patients presented a cortisol/DHEA ratio significantly higher than HIV+, HIV-LTB and HD individuals. A positive correlation was observed between DHEA-s and CD4 count among HIV-TB individuals. Conversely, cortisol plasma level inversely correlated with CD4 count within HIV-TB individuals. M. tuberculosis-specific Th1 lymphocyte count was increased after culturing PBMC from HIV-TB individuals in presence of DHEA. We observed an inverse correlation between DHEA-s plasma level and Treg frequency in co-infected individuals, and CD4+FoxP3+ Treg frequency was increased in HIV-TB and IRIS patients compared to other groups. Strikingly, we observed a prominent CD4+CD25-FoxP3+ population across HIV-TB and HIV-TB IRIS patients, which frequency correlated with DHEA plasma level. Finally, DHEA treatment negatively regulated FoxP3 expression without altering Treg frequency in co-infected patients. These data suggest an enhancing role for DHEA in the immune response against M. tuberculosis during HIV-TB coinfection and IRIS.